Panel Discussion: Exploring Opportunities With ADC Regulatory CMC & Making the Most of Sponsor- Regulator Interactions

  • ADC regulatory submissions under accelerated timelines: Is it clear what is must have versus nice to have?
  • Comparing ADC regulatory CMC guidelines across global Health authorities
  • Assessing prioritizations for future industry-regulator interactions and science-based justifications for alternative control strategies